Customer updates

UPDATE: Temporary interruption to supply

28 May 2020

Latest update:

The cause of the supply interruption has been identified and is currently being rectified.

Generator dispatch is planned to recommence on Monday 1 June and all back orders will cleared by Thursday 4 June.

Our Service team are working through customer requirements individually and will be in touch throughout Thursday and Friday this week to confirm resupply deliveries. We appreciate the urgent nature of this situation and want to make sure we are providing you with the best possible information to meet your needs.

In addition, ANSTO has a number of pre-made Iodine 131 capsules available and will be importing Lutetium 177 from ITG on available flights out of Europe for the next two weeks.

Following a set recovery plan, the ANSTO health products team expect to return to the current supply
pattern by Thursday 4 June. Further contingencies are in place should the plan not proceed as expected.

We would like to thank members of the Nuclear Medicine Working Group, AANMs and ANZSNM for their
guidance, assistance and support.

Our Customer Service team are here to help
Phone: 1800 251 572 or +61 2 9717 9992 or Email: health@ansto.gov.a

UPDATE: Pentastan Kit Product Information

27 May 2020

Yesterday, a customer brought to our attention the labelling on our Pentastan Kit and its product information (PI) is out of date. This is because we’ve updated our manufacturer and the labelling has not yet been refreshed.

We’re working on having the label updated as soon as possible – this should be complete by next Friday 5 June. In the meantime, here’s a quick summary for you:

There is no change to the way you use this product, please follow instructions outlined in the prescribing information
The DTPA in the kit is stored under nitrogen rather than vacuum
The updated PI is available via our website

We apologise for any inconvenience this has caused. Please reach out if you have any questions via the contact details below.

Phone: 1800 251 572 or +61 2 9717 9992 or Email: health@ansto.gov.au

UPDATE: ANSTO scheduled maintenance

26 May 2020

As previously communicated, ANSTO will undertake scheduled preventative maintenance shutdown of the OPAL Reactor and Mo-99 Production facility. The dates of the shutdown have been amended and will occur from 9 June to 27 June 2020.

During the period of this shut-down, ANSTO will work with our international manufacturing and logistical partners to facilitate the continuity of supply.

As part of the Australian Government’s commitment to the nuclear medicine community, ANSTO will ensure any additional costs associated with importing product will be absorbed and not be passed on to our customers.

Thank you to the Nuclear Medicine Advisory Board and Working Group, with representation from RAINS, ANZSNM, AANMS, NSW Health, TGA and GMS, who have helped to communicate the importance of this scheduled maintenance work to support the long term reliability of supply.

Next Steps:
Please contact our Customer Service Team if you have further questions and to help you better identify your options during the preventative maintenance shutdown period.

A table outlining the adjustment to supply of products can be viewed via this link.

You can also contact the Customer Service Team on:
Phone: 1800 251 572 or + 61 2 9717 9992 or Email: health@ansto.gov.au